Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GTHX | Common Stock | Options Exercise | $5.85K | +15K | +12.93% | $0.39* | 131K | Oct 18, 2022 | Direct | |
transaction | GTHX | Common Stock | Sale | -$175K | -15K | -11.45% | $11.70* | 116K | Oct 18, 2022 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GTHX | Stock Option (Right to Buy) | Options Exercise | $0 | -15K | -20.75% | $0.00 | 57.3K | Oct 18, 2022 | Common Stock | 15K | $0.39 | Direct | F3 |
Id | Content |
---|---|
F1 | The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. |
F2 | The price represents the weighted average price with a low of $11.51 and a high of $11.94. The Reporting Person undertakes to provide G1 Therapeutics, Inc., any security holder of G1 Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth. |
F3 | All shares underlying this option have vested. |